Provided by Tiger Fintech (Singapore) Pte. Ltd.

CRISPR Therapeutics AG

52.17
+0.50000.97%
Post-market: 52.170.00000.00%16:58 EDT
Volume:1.84M
Turnover:95.50M
Market Cap:4.51B
PE:-11.55
High:53.08
Open:52.36
Low:51.15
Close:51.67
Loading ...

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Motley Fool
·
08 May

Crispr Therapeutics Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
08 May

Analysts’ Top Healthcare Picks: Crispr Therapeutics AG (CRSP), Neuren Pharmaceuticals Limited (NURPF)

TIPRANKS
·
08 May

Evercore ISI Remains a Buy on Crispr Therapeutics AG (CRSP)

TIPRANKS
·
08 May

These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results

Benzinga
·
07 May

Stock Track | CRISPR Therapeutics Soars 6.79% Pre-market Amid Medical AI Stock Rally and Positive Analyst Rating

Stock Track
·
07 May

Stock Track | CRISPR Therapeutics Soars 6.79% Pre-market on Chardan Capital's Buy Rating, Despite Mixed Analyst Views

Stock Track
·
07 May

Crispr Therapeutics Is Maintained at Buy by Chardan Capital

Dow Jones
·
07 May

Crispr Therapeutics AG: Balancing Growth Potential with Profitability Challenges – Hold Rating

TIPRANKS
·
07 May

24H|Crypto Shares Gain; Canaan up 10%; Riot Platforms up 5%; Medical AI Stocks Rise; RXRX up 4%; Gold Shares Fall

Tiger Newspress
·
07 May

CRISPR Therapeutics AG reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

CRISPR Therapeutics Q1 EPS $(1.58) Misses $(1.21) Estimate, Sales $865.00K

Benzinga
·
07 May

Crispr Therapeutics AG (CRSP) Gets a Hold from TD Cowen

TIPRANKS
·
06 May

Editas Medicine to Announce First Quarter 2025 Financial Results and to Participate in Investor Conference in May

GlobeNewswire
·
06 May

Liquidia Technologies (LQDA) Surges 13.2%: Is This an Indication of Further Gains?

Zacks
·
05 May

CRISPR Therapeutics AG (CRSP) Advances But Underperforms Market: Key Facts

Zacks
·
03 May

Medical AI Stocks Soared. HIMS up 7%; Tempus up 6%; RXRX up 4%; Ginkgo up 3%.

Tiger Newspress
·
02 May

2 Beaten-Down Stocks With Incredible Upside Potential

Motley Fool
·
30 Apr

Kytopen and Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative CRISPR-mediated Cellular Engineering Workflow

PR Newswire
·
29 Apr

US Health Secretary Reportedly Says 35 States to Join Pilot Program for Sickle Cell Disease Gene Therapies

MT Newswires Live
·
26 Apr